Development of Next-Generation Peptide Binders Using In vitro Display Technologies and Their Potential Applications

Area of Science:

• Biotechnology
• Drug Discovery
• Molecular Medicine

Background:

• Monoclonal antibodies are key molecular targeting drugs but face development and prescription challenges.
• Synthetic peptides are emerging as potential alternatives due to their specificity and affinity.
• In vitro display technologies enable selection of peptides from large combinatorial libraries.

Purpose of the Study:

• To review the current state of in vitro display selection for synthetic peptide binders.
• To compare selected peptides with natural counterparts regarding affinity and activity.
• To assess the therapeutic potential of synthetic peptides as alternatives to antibody drugs.

Main Methods:

• In vitro display technologies for selecting peptide binders from combinatorial libraries.
• Comparative analysis of selected synthetic peptides and natural peptides/proteins.
• Review of therapeutic applications and potential of synthetic peptide binders.

Main Results:

• In vitro display is effective for selecting specific peptide binders.
• Amino acid sequences and structural frameworks determine target affinities and inhibitory activities.
• Selected peptides show potential for therapeutic applications.

Conclusions:

• Synthetic peptide binders are viable alternatives to antibody drugs.
• In vitro display technologies are crucial for developing novel peptide therapeutics.
• Further research can optimize peptide binders for enhanced efficacy and safety.